Drug name - Zegalogue
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US10442847 | ZEALAND PHARMA | Glucagon analogues |
Feb, 2035
(12 years from now) | |
| CN104662038A | ZEALAND PHARMA | Glucagon Analogues |
Jul, 2033
(10 years from now) | |
| CN104662038B | ZEALAND PHARMA | Glucagon Analogs |
Jul, 2033
(10 years from now) | |
| IN201500544P1 | ZEALAND PHARMA | Glucagon Analogues |
Jul, 2033
(10 years from now) | |
| IN346936B | ZEALAND PHARMA | Glucagon Analogues |
Jul, 2033
(10 years from now) | |
| EP2875043A1 | ZEALAND PHARMA | Glucagon Analogues |
Jul, 2033
(10 years from now) | |
| EP2875043B1 | ZEALAND PHARMA | Glucagon Analogues |
Jul, 2033
(10 years from now) | |
Drugs and Companies using DASIGLUCAGON HYDROCHLORIDE ingredient
Treatment: NA
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML) | SOLUTION;SUBCUTANEOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.